$ZTS (-2.04%) You are close to the 52-week low, if the support holds it may go up again. Pros are the high market value, the company makes a profit and pays dividends. Cons are the fundamental data such as P/E ratio and P/B ratio. I will take a look at $ELAN (+2.43%) , $PETS (+3.99%)
$PETQ (-0.36%) in the watchlist
PETPetIQUS71639T1060PETQPETQ
PET
PetIQ
US71639T1060
PETQ
PETQ
5Mon·
1 Comment
~ Michael 💎 🏅@Michael-official
5Mon
•
1414
•Financials
Market Cap
$927.49M5Y beta
1.74EPS (TTM)
$0.38Free Float
27.82MP/E ratio (TTM)
80.96Revenue (TTM)
$1.13BEBITDA (TTM)
$116.56MFree Cashflow (TTM)
$11.98MPricing
1D span
$30.60$31.21
52W span
$15.09$30.84
Analyst Ratings
The price target is $29.00 and the stock is covered by 5 analysts.
Buy
4
Hold
1
Sell
0
Information
1933Biotechnology & DrugsHealth Care
PetIQ, Inc. is a pet medication and wellness company, which provides veterinary products and services. The Company operates through two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to major United States retail and e-commerce channels through more than 60,000 points of distribution. It is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 39 states. The segment’s services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks. The Rx pet medications products include flea and tick control, heartworm preventatives, arthritis, thyroid, and other specialty medications.
Identifier
ISIN
US71639T1060
Primary Ticker
PETQ